Rice University

Rice University is a private research institution located in Houston, Texas, established in 1912. It emphasizes education across various fields, including humanities, sciences, and engineering, creating an environment that fosters diversity and intellectual growth. The university prioritizes close relationships between students and faculty, facilitating personalized academic experiences that enhance learning and research initiatives. Through its commitment to academic excellence, Rice University supports a wide range of programs, including scholarships, professorships, and fellowships, contributing to both basic research and public service initiatives.

Allison Thacker

Special Advisor to Rice University

8 past transactions

Greentown Labs

Debt Financing in 2024
Established in 2011, Greentown Labs offers shared workspace, prototyping facilities, and event spaces for businesses focused on climate technology, clean energy, and environmental industries. Its mission is to foster a vibrant community of entrepreneurs by providing access to resources, funding, and collaborative spaces.

Greentown Labs

Grant in 2024
Established in 2011, Greentown Labs offers shared workspace, prototyping facilities, and event spaces for businesses focused on climate technology, clean energy, and environmental industries. Its mission is to foster a vibrant community of entrepreneurs by providing access to resources, funding, and collaborative spaces.

Mallard Bay

Grant in 2022
Mallard Bay operates an online marketplace and booking platform for hunting and fishing adventures. It connects sportsmen with safe, reliable hunting and fishing spots and helps users discover, compare, and book guided trips. The service includes secure payment processing and back-office tools that help guides showcase trips, manage bookings, and handle payments, enabling providers to run their operations efficiently and clients to plan outdoor experiences with ease.

TransCrypts

Seed Round in 2021
TransCrypts automates issuance of employment and income verification documents for HR departments using blockchain technology. This streamlines compliance processes, saving time and resources, while empowering employees to control how their work information is shared.

RANDIAN

Seed Round in 2019
RANDIAN offers a patented interactive platform that combines video content with e-commerce. It enables users to shop for clothing seen on characters in shows while watching, driving direct sales for brands and increasing viewer engagement.

OncoResponse

Series B in 2018
OncoResponse is an immuno‑oncology biotechnology company that uses a proprietary human antibody platform to discover novel targets and develop fully human monoclonal antibodies for cancer treatment. By interrogating the adaptive immune system of patients who respond exceptionally well to checkpoint inhibition, the company identifies genuine human antibodies against high‑value targets linked with immunosuppressive myeloid biology. Its pipeline aims to alleviate tumor‑microenvironment immunosuppression and enhance immune activation, converting cold tumors into hot ones and providing new therapeutic options for patients.

Medical Magnesium

Seed Round in 2017
Medical Magnesium specializes in developing metallic bioabsorbable implants for orthopedic and trauma surgery. Their innovative magnesium-based solutions are mechanically stable during healing but physiologically degrade afterwards, eliminating the need for metal removal surgeries.

OncoResponse

Series A in 2016
OncoResponse is an immuno‑oncology biotechnology company that uses a proprietary human antibody platform to discover novel targets and develop fully human monoclonal antibodies for cancer treatment. By interrogating the adaptive immune system of patients who respond exceptionally well to checkpoint inhibition, the company identifies genuine human antibodies against high‑value targets linked with immunosuppressive myeloid biology. Its pipeline aims to alleviate tumor‑microenvironment immunosuppression and enhance immune activation, converting cold tumors into hot ones and providing new therapeutic options for patients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.